26 Result(s)

Article

Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes)

B. Schneider, S. Martin, W. A. Scherbaum, L. Heinemann, V. Lodwig, H. Kolb in Diabetologia (2011)

Article

Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study

Subclinical inflammation confers an increased risk of type 2 diabetes, cardiovascular disease, neurodegenerative disorders and other age-related chronic diseases. Physical activity and diet can attenuate syste...

C. Herder, M. Peltonen, W. Koenig, K. Sütfels, J. Lindström, S. Martin… in Diabetologia (2009)

Article

Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials

K. Kempf, W. Neukirchen, S. Martin, H. Kolb in Diabetologia (2008)

Article

Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002

Macrophage migration inhibitory factor (MIF) is a central mediator of innate immunity. Our aim was to investigate the triangular association between MIF genotypes, circulating MIF concentrations and incident type...

C. Herder, N. Klopp, J. Baumert, M. Müller, N. Khuseyinova, C. Meisinger… in Diabetologia (2008)

Article

Comment on: Davidson MB (2007) The dilemma of self-monitoring of blood glucose. Diabetologia 50:497–499

H. Kolb, S. Martin, A. J. Karter in Diabetologia (2007)

Article

Reply to comment on: Martin S, Schneider B, Heinemann L et al (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49:271–278

S. Martin, L. Heinemann, W. A. Scherbaum, H. Kolb in Diabetologia (2006)

Article

Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002

The chemokines monocyte chemoattractant protein-1 (MCP-1), IL-8 and interferon-γ-inducible protein-10 (IP-10) are released by adipocytes and appear to be involved in atherosclerosis. We hypothesised that these...

C. Herder, J. Baumert, B. Thorand, W. Koenig, W. de Jager, C. Meisinger… in Diabetologia (2006)

Article

Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study

The aim of this study was to obtain epidemiological data on self-monitoring of blood glucose (SMBG) in type 2 diabetes and to investigate the relationship of SMBG with disease-related morbidity and mortality.

S. Martin, B. Schneider, L. Heinemann, V. Lodwig, H.-J. Kurth, H. Kolb… in Diabetologia (2006)

Article

Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation

Diabetic distal symmetrical sensory polyneuropathy (DSP) affects 20–30% of diabetic patients. Transcutaneous electrical nerve stimulation (TENS) and electrical spinal cord stimulation have been proposed as phy...

L. Reichstein, S. Labrenz, D. Ziegler, S. Martin in Diabetologia (2005)

Article

40^th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt… in Diabetologia (2004)

Article

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors

Aims/hypothesis. A population-based sample was studied to define immune abnormalities in individuals at risk of Type II (non-insulin-dependent) diabetes mellitus because of impaired glucose toler...

S. Müller, S. Martin, W. Koenig, P. Hanifi-Moghaddam, W. Rathmann… in Diabetologia (2002)

Article

Modulation of autoimmunity to beta-cell antigens by proteases

Aims/hypothesis. Proteases are used in therapy for autoimmune diseases yet the mechanism of their action remains to be determined. We studied the immunological basis of protease therapy in the co...

B. Roep, N. van den Engel, A. van Halteren, G. Duinkerken, S. Martin in Diabetologia (2002)

Article

Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes

Increased concentration of circulating adhesion molecules in human serum have been described in different immune-mediated diseases. Recently, we proposed an immunomodulatory function of soluble forms of the i...

S. Martin, E. Heidenthal, B. Schulte, H. Rothe, H. Kolb in Diabetologia (1998)

Article

Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2

The macrophage product interleukin (IL)-12 is known to drive Th1 reactions in physiological and pathological immune responses. Here we report that treatment with the homodimeric IL-12p40 subunit, an antagonis...

H. Rothe, R. M. O'Hara, S. Martin, H. Kolb in Diabetologia (1997)

Article

Autoantibodies to the islet antigen ICA 69 occur in IDDM and in rheumatoid arthritis

Islet cell antigen (ICA) 69 is a newly-recognized islet cell antigen to which autoantibodies have been observed in prediabetic relatives of patients with insulin-dependent-diabetes mellitus (IDDM). Here we ext...

S. Martin, J. Kardorf, B. Schulte, E. F. Lampeter, F. A. Gries, I. Melchers… in Diabetologia (1995)

Article

Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4

In pancreatic lesions of non-obese diabetic (NOD) mice the expression of inducible nitric oxide synthase (iNOS) and of the cytokines interferongamma and interleukin-4 were studied. Strong iNOS expression as de...

H. Rothe, A. Faust, U. Schade, R. Kleemann, G. Bosse, T. Hibino, S. Martin… in Diabetologia (1994)

Article

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

Arterial hypertension has been identified as a major secondary risk factor for diabetic retinopathy. However, the mechanisms by which hypertension worsens retinopathy are unknown. Inhibition of advanced glycat...

Dr. H. -P. Hammes, M. Brownlee, D. Edelstein, M. Saleck, S. Martin… in Diabetologia (1994)